RT Journal Article
SR Electronic
T1 Curating, collecting, and cataloguing global COVID-19 datasets for the aim of predicting personalized risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.14.21265797
DO 10.1101/2021.11.14.21265797
A1 Khatami, Sepehr Golriz
A1 Russo, Maria Francesca
A1 Domingo-Fernández, Daniel
A1 Zaliani, Andrea
A1 Mubeen, Sarah
A1 Gadiya, Yojana
A1 Sargsyan, Astghik
A1 Karki, Reagon
A1 Gebel, Stephan
A1 Ruppa Surulinathan, Ram Kumar
A1 Lage-Rupprecht, Vanessa
A1 Archipovas, Saulius
A1 Mingrone, Geltrude
A1 Jacobs, Marc
A1 Claussen, Carsten
A1 Hofmann-Apitius, Martin
A1 Kodamullil, Alpha Tom
A1 the COPERIMOplus consortium
YR 2021
UL http://medrxiv.org/content/early/2021/11/15/2021.11.14.21265797.abstract
AB The COVID-19 data catalogue is a repository that provides a landscape view of COVID-19 studies and datasets as a putative source to enable researchers to develop personalized COVID-19 predictive risk models. The COVID-19 data catalogue currently contains over 400 studies and their relevant information collected from a wide range of global sources such as global initiatives, clinical trial repositories, publications and data repositories. Further, the curated content stored in this data catalogue is complemented by a web application, providing visualizations of these studies, including their references, relevant information such as measured variables, and the geographical locations of where these studies were performed. This resource is one of the first to capture, organize and store studies, datasets and metadata in the area of COVID-19 in a comprehensive repository. We are convinced that our work will facilitate future research and development of personalized predictive risk models of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was conducted in the context of the 'COPERIMOplus' initiative and supported by the Fraunhofer 'Internal Programs Fraunhofer vs Corona' under Grant No. Anti-Corona 840266.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Catholic University of the Sacred Heart gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data should be applied from Catholic University of the Sacred Heart